Mazor breakout is not a fakeout

2017年3月25日

I have been following this Mazor story for over a year, since Medtronic took a stake in them. They are selling their robotic systems well in the US and europe. With Medtronic financial and sales support, as well as their updated systems, this year should be a breakout one. Current target is 60, although longer term I believe it will be much higher (unless they get bought out by Medtronic).

2017年4月30日

ノート

This is working as planned. I personally sold thinking it would dip again. That was a mistake. I will be buying it back, at least partially, before earnings.